Auro Laboratories Ltd. (AUROLAB): Auro Laboratories Share Price rises 8.21%: what drove AUROLAB today?
- September 3, 2026
- Posted by: Harsh Piplani
- Category: News
Auro Laboratories Share Price is in focus today after AUROLAB traded at Rs 263, up 8.21% from the previous close, with market capitalisation at Rs 151.48 Cr. The move puts Auro Laboratories Ltd. among the stocks in news on a day when the latest Univest data confirms a clear price rise, but does not establish a company-specific catalyst. That makes the move relevant for investors tracking Auro Laboratories Share Price Today, especially because the stock has also moved through a wide intraday band and is drawing attention in the Indian Stock Market as a small-cap healthcare name.
For readers following Auro Laboratories Stock News, the key question is not only why the stock is rising today, but also whether the current valuation and business context justify the interest. According to latest Univest data, the company is trading in the Pharmaceuticals & Drugs industry within Healthcare, where relative value, scale and peer positioning matter. Univest users can also track Auro Laboratories Share Price Live, Share Price Update and Auro Laboratories Latest News to understand how the move fits into broader Market News and Stocks Rising Today themes.
Auro Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 263 |
| Previous Close | Rs 243.05 |
| Today's Move | Rs 19.95 (+8.21%) |
| Open | Rs 247.95 |
| High | Rs 267.8 |
| Low | Rs 246 |
| Turnover | Rs 0.52 crore |
| Market Capitalisation | Rs 151.48 crore |
| Market Cap Category | Micro Cap |
Auro Laboratories Ltd. (AUROLAB) rose to Rs 263 from the previous close of Rs 243.05, a move of Rs 19.95 or 8.21%. The stock opened at Rs 247.95, reached a high of Rs 267.8, recorded a low of Rs 246.
Auro Laboratories Share Price Today reflects a Rs 19.95 gain from the previous close of Rs 243.05, with the stock last traded at Rs 263. The day opened at Rs 247.95, touched a high of Rs 267.8 and a low of Rs 246, showing an active share price rise within the day’s range. Turnover stood at Rs 0.52 Cr, which shows trading interest in a small-cap counter even as the move remains company-specific only in price terms. For Auro Laboratories Share News and AUROLAB Stock Performance, the latest Univest figures confirm the event without assigning an unverified trigger.
Auro Laboratories Ltd. (AUROLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 151.48 crore |
| P/E Ratio | 32.35x |
| P/B Ratio | 3.2x |
| ROE | 7.91% |
| ROCE | 9.17% |
| EPS | Rs 7.51 |
| Book Value Per Share | Rs 76.04 |
| Dividend Yield | 0% |
Auro Laboratories Ltd. (AUROLAB) fundamental metrics show P/E 32.35x, P/B 3.2x, ROE 7.91%, ROCE 9.17%. These figures provide context only and are not a buy or sell signal.
Auro Laboratories Ltd. has a market capitalisation of Rs 151.48 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 32.35x, P/B at 3.2x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.91% and ROCE of 9.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7.51, book value per share of Rs 76.04, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.97x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 32.35x |
| Benchmark Median P/E | 31.97x |
| Benchmark Average P/E | 48.6x |
| Benchmark P/E Range | 3.49x to 648.54x |
| Company P/B Ratio | 3.2x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 7.91% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 9.17% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 151.48 crore |
| Benchmark Median Market Cap | Rs 727.27 crore |
Auro Laboratories Ltd. (AUROLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Auro Laboratories Ltd. (AUROLAB) has a P/E ratio of 32.35x, which is above the benchmark median of 31.97x, a difference of +1.19%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Auro Laboratories Ltd. (AUROLAB) has a ROE of 7.91%, which is below the benchmark median of 11.79%, a difference of -32.91%. Auro Laboratories Ltd. (AUROLAB) has a ROCE of 9.17%, which is below the benchmark median of 13.63%, a difference of -32.72%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,63,179.62 | 38.34 | 5.36 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,43,301.95 | 83.79 | 13.88 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,88,622.52 | 87.28 | 21.21 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,16,114.43 | 25.44 | 4.26 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.87 | 3.25 | 11.83 | 16 |
Auro Laboratories Ltd. (AUROLAB) has a P/E ratio of 32.35x compared with the displayed peer median of 38.34x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.91% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 9.17% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Auro Laboratories Ltd. (AUROLAB) has a market capitalisation of Rs 151.48 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Auro Laboratories
- Auro Laboratories Share Price rose 8.21% today, making AUROLAB a notable stock in news.
- The stock last traded at Rs 263, above the previous close of Rs 243.05, which keeps Auro Laboratories Share Price Today in focus.
- Market capitalisation of Rs 151.48 Cr places the company in the small-cap healthcare segment.
- P/E of 32.35, P/B of 3.2, ROE of 7.91% and ROCE of 9.17% give a clear fundamental context.
- The company trades in Pharmaceuticals & Drugs, where peer comparison and sector context matter for Auro Laboratories Stock Analysis.
About Auro Laboratories
Auro Laboratories Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company’s latest market profile shows a small listed healthcare business with Auro Laboratories Share Price moving to Rs 263 and market capitalisation at Rs 151.48 Cr. For investors reading Auro Laboratories Stock News, the company’s scale matters because smaller pharma names are often judged more on business stability, margins and relative valuation than on brand-driven market narratives.
At this stage, the key public facts available for Auro Laboratories Share Price analysis are its listed-sector identity, valuation ratios and return metrics rather than a detailed segment breakdown. That makes the latest Univest figures useful for comparing the company against larger industry names and understanding where it stands in the healthcare universe. Univest readers looking at Auro Laboratories Share Price Today can use this profile as a starting point for monitoring future company updates and financial results.
Frequently Asked Questions
Why is Auro Laboratories Share Price rising today?
Ans. Auro Laboratories Share Price rose 8.21% today to Rs 263, but the verified market data does not establish a company-specific catalyst. The move is still relevant because it happened alongside active price action and a small-cap market capitalisation of Rs 151.48 Cr.
What is Auro Laboratories Share Price today?
Ans. Auro Laboratories Share Price today is Rs 263, which is Rs 19.95 above the previous close of Rs 243.05. The stock traded between Rs 246 and Rs 267.8 during the day.
How much did AUROLAB rise today?
Ans. AUROLAB rose 8.21% in the latest trading session. That share price gain took the stock from the previous close of Rs 243.05 to a last traded price of Rs 263.
What is the market cap of Auro Laboratories?
Ans. Auro Laboratories has a market capitalisation of Rs 151.48 Cr. That makes it a small-cap healthcare company, which is useful context when comparing Auro Laboratories Share Price with larger pharmaceutical peers.
What is Auro Laboratories’ valuation?
Ans. Auro Laboratories trades at a P/E ratio of 32.35 and a P/B ratio of 3.2. EPS is Rs 7.51 and book value is Rs 76.04, which helps frame the current Auro Laboratories Share Price.
How does Auro Laboratories compare with healthcare peers?
Ans. Auro Laboratories is much smaller than peers such as Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals. Its P/E is close to the industry median, while ROE and ROCE trail the benchmark set.
What do Auro Laboratories’ ROE and ROCE show?
Ans. ROE is 7.91% and ROCE is 9.17%, both below the same-industry median. These ratios suggest the Auro Laboratories Share Price is being viewed against modest return generation, not just daily movement.
Should investors track Auro Laboratories Share Price on Univest?
Ans. Yes, investors tracking Auro Laboratories Share Price can monitor live price action, market cap, valuation ratios and sector context on Univest. That helps place a one-day rise within the broader healthcare stock picture.
Track Auro Laboratories Share Price on Univest
Use Auro Laboratories Ltd. (AUROLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Univest helps users track Auro Laboratories Share Price Live, Auro Laboratories Share Price Today, valuation ratios, market cap, and broader market insights in one place. You can follow Auro Laboratories Stock News, Auro Laboratories Share News, 52-week levels and company fundamentals on Univest as part of a broader stock analysis workflow.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
